$NKTR NEKTAR THERAPEUTICS Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in NEKTAR THERAPEUTICS. Find out how many shares they currently own, their value and whether they buy or sell their shares.
NEKTAR THERAPEUTICS Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Ajer Jeffrey Robert | Director | 25,975 | 342,091 | Sep 30 2020 | |||
BANSAL AJAY | CFO, VP Finance & Admin | 10,333 | 136,086 | Mar 13 2006 | |||
BROWN MICHAEL A/CA | Director | 0 | 0 | Sep 22 2006 | |||
CHESS ROBERT | Director | 288,573 | 3,800,506 | May 14 2021 | 23 months ago | ||
CHESS ROBERT | Chairman of the Board | 240,792 | 3,171,231 | Mar 22 2007 | |||
CHESS ROBERT | Director | 255,123 | 3,359,970 | Sep 16 2010 | |||
CHESS ROBERT | Director | 260,623 | 3,432,405 | Dec 31 2014 | |||
CHOWRIRA BHARAT M | Chief Operating Officer | 0 | 0 | Feb 03 2010 | |||
Doberstein Stephen K | SVP & Chief Scientific Officer | 107,668 | 1,417,988 | Sep 09 2019 | |||
Doberstein Stephen K | SVP & Chief Scientific Officer | 0 | 0 | Feb 07 2014 | |||
Doberstein Stephen K | SVP & Chief Scientific Officer | 0 | 0 | Dec 11 2014 | |||
DRAPEAU LOUIS | Sr. VP Finance, CFO | 6,000 | 79,020 | May 14 2007 | |||
EASTHAM KARIN | Director | 24,100 | 317,397 | Sep 24 2020 | |||
Elam Nevan C | SVP, Head Pulmonary Bus. Unit | 1,400 | 18,438 | May 15 2007 | |||
Elam Nevan C | SVP & Head of Pulmonary Bus | 0 | 0 | Feb 27 2008 | |||
Gergel Ivan | SVP & Chief Medical Officer | 61,575 | 810,943 | Nov 17 2017 | |||
Gergel Ivan P. | SVP Drug Development & CMO | 0 | 0 | May 19 2014 | |||
Gergel Ivan P. | SVP & Chief Medical Officer | 0 | 0 | Dec 11 2014 | |||
Ghosh Rinko | Chief Business Officer | 0 | 0 | Feb 10 2011 | |||
Ghosh Rinko | Chief Business Officer | 14,386 | 189,464 | Feb 08 2013 | |||
GILL AJIT | President & CEO | 87,991 | 1,158,841 | Mar 24 2006 | |||
GREER R SCOTT | Director | 185,674 | 2,445,327 | Sep 24 2020 | |||
GREER R SCOTT | Director | 0 | 0 | Sep 16 2010 | |||
GREER R SCOTT | Director | 50,833 | 669,471 | Sep 25 2014 | |||
HARKNESS TIMOTHY | SVP & Chief Financial Officer | 0 | 0 | Aug 24 2007 | |||
HARRIS J MILTON | President of Nektar AL | 743,904 | 9,797,216 | Mar 08 2004 | |||
Hora Maninder | SVP Pharma Dev & Mfg Ops | 94,694 | 1,247,120 | May 17 2019 | |||
Hora Maninder | SVP Pharma Dev and Mfg | 0 | 0 | Feb 07 2014 | |||
Hora Maninder | SVP Pharma Dev & Mfg Ops | 0 | 0 | Dec 11 2014 | |||
Huh Hoyoung | Director | 0 | 0 | Dec 04 2008 | |||
Johnston David | SVP, Research & Development | 6,600 | 86,922 | May 15 2007 | |||
Krivulka Joseph J | Director | 82,000 | 1,079,940 | Sep 21 2017 | |||
Krivulka Joseph J | Director | 0 | 0 | Sep 26 2014 | |||
Krivulka Joseph J | Director | 0 | 0 | Sep 22 2006 | |||
Krivulka Joseph J | Director | 10,000 | 131,700 | Sep 16 2010 | |||
Krivulka Joseph J | Director | 20,000 | 263,400 | Sep 23 2013 | |||
KUEBLER CHRISTOPHER A | Director | 45,250 | 595,943 | Oct 01 2018 | |||
KUEBLER CHRISTOPHER A | Director | 0 | 0 | Sep 22 2006 | |||
KUEBLER CHRISTOPHER A | Director | 5,000 | 65,850 | Sep 16 2010 | |||
KUEBLER CHRISTOPHER A | Director | 20,000 | 263,400 | Sep 25 2014 | |||
KUEBLER CHRISTOPHER A | Director | 20,000 | 263,400 | Jan 15 2015 | |||
Labrucherie Gil M | SVP, COO & CFO | 258,996 | 3,410,977 | Feb 18 2021 | |||
Labrucherie Gil M | SVP & General Counsel | 2,662 | 35,059 | Feb 10 2011 | |||
Labrucherie Gil M | SVP & General Counsel | 4,251 | 55,986 | Dec 11 2014 | |||
LERNER IRWIN | Director | 0 | 0 | Sep 19 2005 | |||
LERNER IRWIN | Director | 0 | 0 | Sep 22 2006 | |||
LERNER IRWIN | Director | 10,000 | 131,700 | Dec 04 2008 | |||
Lingnau Lutz | Director | 35,800 | 471,486 | Sep 24 2020 | |||
Lingnau Lutz | Director | 6,450 | 84,947 | Sep 16 2010 | |||
Lingnau Lutz | Director | 16,450 | 216,647 | Nov 26 2014 | |||
Lorianne Masuoka K. | Chief Medical Officer | 0 | 0 | Feb 10 2011 | |||
Medve Robert | SVP & Chief Medical Officer | 0 | 0 | Feb 07 2014 | |||
Moreadith Randall W | SVP Drug Development | 0 | 0 | Feb 25 2009 | |||
Myriam Curet | Director | 19,240 | 253,391 | Dec 17 2020 | |||
Nicholson John | SVP & Chief Operating Officer | 162,759 | 2,143,536 | Aug 19 2019 | |||
Nicholson John | SVP & Chief Financial Officer | 10,000 | 131,700 | Dec 11 2014 | |||
NORTHCOTT JOHN | SVP & Chief Commercial Officer | 207,107 | 2,727,599 | May 19 2021 | 22 months ago | ||
PATTON JOHN STUART | Chief Scientific Officer | 311,864 | 4,107,249 | May 15 2007 | |||
PATTON JOHN STUART | Chief Scientific Officer | 313,880 | 4,133,800 | Nov 18 2008 | |||
PERELMAN MELVIN | Director | 0 | 0 | Sep 03 2004 | |||
ROBIN HOWARD W | President & CEO | 447,198 | 5,889,598 | Feb 18 2021 | |||
ROBIN HOWARD W | President & CEO | 10,000 | 131,700 | Mar 05 2007 | |||
ROBIN HOWARD W | President & CEO | 0 | 0 | Feb 10 2011 | |||
ROBIN HOWARD W | President & CEO | 10,000 | 131,700 | Dec 11 2014 | |||
Thomsen Jillian B. | SVP & Chief Accounting Officer | 164,552 | 2,167,150 | Feb 18 2021 | |||
Thomsen Jillian B. | SVP & Chief Accounting Officer | 2,999 | 39,497 | Dec 24 2014 | |||
WANG SUSAN | Director | 20,000 | 263,400 | Nov 20 2015 | |||
WANG SUSAN | Director | 0 | 0 | Sep 22 2006 | |||
WANG SUSAN | Director | 10,000 | 131,700 | Sep 16 2010 | |||
WANG SUSAN | Director | 20,000 | 263,400 | Sep 25 2014 | |||
WHITFIELD ROY A | Director | 185,850 | 2,447,645 | Jan 04 2021 | |||
WHITFIELD ROY A | Director | 20,000 | 263,400 | Sep 25 2014 | |||
WHITFIELD ROY A | Director | 0 | 0 | Sep 22 2006 | |||
WHITFIELD ROY A | Director | 10,000 | 131,700 | Sep 16 2010 | |||
Wilson Mark Andrew | SVP & General Counsel | 74,810 | 985,248 | May 19 2021 | 22 months ago | ||
WINGER DENNIS L | Director | 57,750 | 760,568 | Aug 21 2018 | |||
WINGER DENNIS L | Director | 0 | 0 | Sep 16 2010 | |||
WINGER DENNIS L | Director | 11,250 | 148,163 | Sep 25 2014 | |||
Zalevsky Jonathan | Chief R&D Officer | 266,176 | 3,505,538 | Feb 18 2021 |